| Patents for C07D 307 - Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom (47,108) |
|---|
| 07/15/2004 | WO2004058785A1 Process for producing 2-deoxyaldose compound |
| 07/15/2004 | WO2004058739A1 1,2,4-triaminobenzene derivatives useful for treating disorders of the central nervous system |
| 07/15/2004 | WO2004058735A2 Ligands of melanocortin receptors and compositions and methods related thereto |
| 07/15/2004 | WO2004058723A1 Biphenyl derivatives and their use as fungicides |
| 07/15/2004 | WO2004058686A1 Hydroxypropyl amides for the treatment of alzheimer’s disease |
| 07/15/2004 | WO2004058679A2 Ligands of adenine nucleotide translocase (ant) and compositions and methods related thereto |
| 07/15/2004 | WO2004058397A1 Ruthenium-molybdenum catalyst for hydrogenation in aqueous solution |
| 07/15/2004 | WO2004058174A2 Indane acetic acid derivatives and their use as pharmaceutical agents, intermediates, and method of preparation |
| 07/15/2004 | WO2004058164A2 Asthma and allergic inflammation modulators |
| 07/15/2004 | WO2004047772A3 Catalytic antioxidants and methods of use |
| 07/15/2004 | WO2004005478A2 Ketone ligands for modulating the expression of exogenous genes via an ecdysone receptor complex |
| 07/15/2004 | WO2003075836A3 Cathepsin cysteine protease inhibitors |
| 07/15/2004 | US20040138497 Production method of citalopram, intermediate therefor and production method of the intermediate |
| 07/15/2004 | US20040138468 Copper-catalyzed formation of carbon-heteroatom and carbon-carbon bonds |
| 07/15/2004 | US20040138301 Chemical uncouplers for the treatment of obesity |
| 07/15/2004 | US20040138297 Administering bicyclic diterpene compound of the labdane to treat menstrual disorders and premenstrual syndrome |
| 07/15/2004 | US20040138271 Benzene compound and salt thereof |
| 07/15/2004 | US20040138261 such as arthritis, pain, fever or cancer; 5-phenyl-1-[3,5-difluoro-4-(methylsulfonyl)phenyl]-3-(trifluoromethyl)-1H-pyrazole for example; cyclooxygenase-2 inhibitors |
| 07/15/2004 | US20040138228 Novel compounds with analgesic effect |
| 07/15/2004 | US20040138225 Analgesics; gastrointestinal disorders; central nervous system injuries |
| 07/15/2004 | US20040138205 Viricides; hepatitis virus |
| 07/15/2004 | US20040138183 Bactericides; anticarcinogenic agents; modulation of gene expression; therapy for antibiotic resistant bacteria |
| 07/15/2004 | US20040135130 Nonlinear optical compounds and methods for their preparation |
| 07/15/2004 | US20040134387 obtained from plant by-products or waste suspended through wet-grinding and suspended by means of a microballs mill; includes silica fume, fly ashes, heavy ashes, slags or stone sludge, in form of pellets, sludge or blocks |
| 07/15/2004 | DE10052803B4 Verfahren zur Herstellung von Mintlacton A process for preparing mint lactone |
| 07/15/2004 | CA2511502A1 1,2,4-triaminobenzene derivatives,useful for treating disorders of the central nervous system |
| 07/15/2004 | CA2511178A1 Ligands of adenine nucleotide translocase (ant) and compositions and methods related thereto |
| 07/15/2004 | CA2489590A1 Ketone ligands for modulating the expression of exogenous genes via an ecdysone receptor complex |
| 07/14/2004 | EP1437346A1 Benzamide derivatives useful as cell differentiation inducers |
| 07/14/2004 | EP1437344A1 Benzene derivatives,process for preparing the same and use thereof |
| 07/14/2004 | EP1436273A1 Substituted piperazine cyclohexane carboxilic acid amides and the use thereof |
| 07/14/2004 | EP1436272A1 Biphenylcarboxylic amide derivatives as p38 kinase inhibitors |
| 07/14/2004 | EP1436255A1 Novel compounds and compositions as cathepsin inhibitors |
| 07/14/2004 | EP1436249A2 Muscarinic agonists |
| 07/14/2004 | EP1436245A1 Method for isolating salts of organic acids from a fermentation broth and for releasing the organic acid |
| 07/14/2004 | EP1435956A2 Therapeutic combinations for cardiovascular and inflammatory indications |
| 07/14/2004 | EP1435942A1 5'-carbamoyl-1,1'-biphenyl-4-carboxamide derivatives and their use as p38 kinase inhibitors |
| 07/14/2004 | EP1435934A1 5'-acylamino-1,1'-biphenyl-4-carboxamide derivatives and their use as p38 kinase inhibitors |
| 07/14/2004 | EP1435933A1 5'-carbamoyl-2'-methyl-1,1'-biphenyl-4-carboxamide derivatives and their use as p38 kinase inhibitors |
| 07/14/2004 | EP1435894A2 Cytoprotective compounds, pharmaceutical and cosmetic formulations, and methods |
| 07/14/2004 | EP1282595B1 Novel phenyl-propargylether derivatives |
| 07/14/2004 | CN1512989A Process for producing ethers |
| 07/14/2004 | CN1512986A Substituted anilide derivatives, intermediates thereof, agricultural and horticultural chemicals and their usage |
| 07/14/2004 | CN1512983A Compounds and compositions as cathepsins inhibitors |
| 07/14/2004 | CN1512982A Novel polyamine analogues as therapeutic and diagnostic agents |
| 07/14/2004 | CN1512882A Reconstitutable parenteral composition containing COX-2 inhibitor |
| 07/14/2004 | CN1512880A Novel compounds and compositions as cathepsin inhibitors |
| 07/14/2004 | CN1511830A Compound used as antiphlogistic |
| 07/13/2004 | US6762321 Amide compounds and use thereof |
| 07/13/2004 | US6762308 Method for the preparation of citalopram |
| 07/13/2004 | US6762307 Method for the preparation of citalopram |
| 07/13/2004 | US6762300 Method for producing 5-(1-piperazinyl)-benzofuran-2-carboxamide by transition metal-catalyzed amination |
| 07/13/2004 | US6762204 Taxol enhancer compounds |
| 07/13/2004 | US6762198 Such as 2-((4'-methoxy-(1,1'-biphenyl)-4-yl)-sulfonyl)-amino-3-(2-phenoxymethyl -(1,3)dioxan-2-yl)propionic acid |
| 07/08/2004 | WO2004056797A1 Aromatic compounds as anti-inflammatory, immunomodulatory and anti-proliferatory agents |
| 07/08/2004 | WO2004056791A1 Escitalopram hydrobromide and a method for the preparation thereof |
| 07/08/2004 | WO2004056764A1 Aromatic derivatives as hiv aspartyl protease inhibitors |
| 07/08/2004 | WO2004056763A2 Novel glucagon antagonists |
| 07/08/2004 | WO2004056754A1 A process for the preparation of racemic citalopram diol and/or s- or r- citalopram diols and the use of such diols for the preparation of racemic citalopram, r-citalopram and/or s-citalopram |
| 07/08/2004 | WO2004056749A1 Process for the synthesis of 3,3a,6,6a-tetrahydro-2h-cyclopentan ‘b ! furan-2-one |
| 07/08/2004 | WO2004056747A1 Dhodh-inhibitors and method for their identification |
| 07/08/2004 | WO2004056746A1 Cycloalkene dicarboxylic acid compounds as anti-inflammatory, immunomodulatory and anti-proliferatory agents |
| 07/08/2004 | WO2004056735A1 2,6-dihalo-4-(3,3-dichloro-allyloxy)-benzylalcohole derivatives having insecticidal and acaricidal properties |
| 07/08/2004 | WO2004056727A2 Process of making chalcone derivatives |
| 07/08/2004 | WO2004051217A3 Process for synthesis bis-aryl diamidoxime compounds |
| 07/08/2004 | WO2004017920A3 Novel biphenyl and biphenyl-like cannabinoids |
| 07/08/2004 | WO2004009017A3 Modulators of the glucocorticoid receptor and method |
| 07/08/2004 | WO2004000764A3 BENZO(b)FURAN DIMERS |
| 07/08/2004 | WO2003103599A3 Caspase-1 inhibitors and methods for their use |
| 07/08/2004 | WO2003062181A8 PROCESS FOR THE PREPARATION OF NONRACEMIC SYN-1-(4-HYDROXY-PHENYL)-2-(4-HYDROXY-4-PHENYL.PIPERIDIN-1Yl)-1-PROPANOL COMPOUNDS |
| 07/08/2004 | US20040133058 Ionic liquids as selective additives for separation of close-boiling or azeotropic mixtures |
| 07/08/2004 | US20040133017 Reducing an unisolable magnesium salt of a benzophenone derivative to form 4-bromo-(2-hydroxymethyl)phenyl-(41-fluorophenyl)methanol, treating with acid catalyst; reacting with copper cyanide, isolation, recrystallization, reacting |
| 07/08/2004 | US20040133007 Process for preparing amine-substituted benzofurans |
| 07/08/2004 | US20040132809 Cell adhesion inhibitors |
| 07/08/2004 | US20040132808 precipitating the citalopram base in crystalline form, and transforming the base into a pharmaceutically acceptable citalopram salt; useful for removing intermediates which are structurally closely related to citalopram |
| 07/08/2004 | US20040132807 Aurones as telomerase inhibitors |
| 07/08/2004 | US20040132800 aminomethyl- or ethyl-substituted indoles, tetrahydrocarbazoles and tetrahydropyrido[1,2-a]indoles |
| 07/08/2004 | US20040132782 Aspartyl protease inhibitors |
| 07/08/2004 | US20040132758 hyterocyclylaminomethyl- or aminocarbonyl-substituted 9,10-ethanoanthracenes or their aza derivatives; treating obesity, diabetes, inflammatory and immune disorders |
| 07/08/2004 | US20040132720 Antidepressants |
| 07/08/2004 | US20040132693 Spiro-cyclic beta-amino acid derivatives as inhibitors of matrix metalloproteases and TNF-alpha converting enzyme (TACE) |
| 07/08/2004 | US20040131883 Furan-containing hole transporting materials |
| 07/08/2004 | CA2511142A1 Escitalopram hydrobromide and a method for the preparation thereof |
| 07/08/2004 | CA2509138A1 Cycloalkene dicarboxylic acid compounds as anti-inflammatory, immunomodulatory and anti-proliferatory agents |
| 07/08/2004 | CA2508272A1 Process for the synthesis of 3,3a,6,6a-tetrahydro-2h-cyclopentan [b] furan-2-one |
| 07/07/2004 | EP1435354A1 Succinic anhydride, process for preparation of the same and use thereof |
| 07/07/2004 | EP1434769A2 Compounds useful as reversible inhibitors of cysteine proteases |
| 07/07/2004 | CN1511404A Method and system for low-overhead mobility management protocol in internet protocol layer |
| 07/07/2004 | CN1511137A Hydro phobic polyamine analogs and methods for their use |
| 07/07/2004 | CN1510024A Compound for preparing citalopram enantiomer and its production |
| 07/07/2004 | CN1156479C Process for extracting raw rotenone |
| 07/07/2004 | CN1156464C Refining process of electron level oxydiphenyl diformic anhydride |
| 07/07/2004 | CN1156452C Compound as anti-inflammatory agent |
| 07/06/2004 | US6759554 Copper-catalyzed formation of carbon-heteroatom and carbon-carbon bonds |
| 07/06/2004 | US6759548 Dialkyl-halogenophenyl-substituted ketoenols |
| 07/06/2004 | US6759409 Inhibitors of papilloma virus |
| 07/01/2004 | WO2004054992A1 Novel retinol derivative and cosmetic composition comprising the same |
| 07/01/2004 | WO2004054982A1 Biphenylcarboxamides |
| 07/01/2004 | WO2004024878A3 Structurally rigid dopamine d3 receptor selective ligands and process for making them |
| 07/01/2004 | WO2004019874A3 Substituted 5-chroman-5-yl-ethylamine compounds and their use for the treatment of glaucoma |